Quantcast

UC Davis Transplant Center

Angelo Mario de Mattos, M.D., M.P.H.

Angelo Mario de Mattos

Philosophy of Care

Coinciding with the mission of the Department of Internal Medicine, my goal is to provide excellence in clinical care, research and education, and to deliver high-quality medical care with commitment to cutting-edge research and superior physician training.

Title:

Associate Professor

Specialty:

Nephrology

Center/Program Affiliation:

Transplant Center

Address:

UC Davis Medical Center - Cypress Building
2221 Stockton Blvd., Suite C
Sacramento, CA 95817

Phone:

(916) 734-2111

Other Languages:

Portuguese, Spanish

Education:

Universidade Federal do Rio de Janeiro
Rio de Janeiro, Brazil
M.D. 1985

Oregon State University - Portland
Portland, Oregon
M.P.H. 2004

Colegio Rio de Janeiro
Rio de Janeiro, Brazil
1979

Internships:

University of Miami Jackson Memorial Medical Center
Miami, FL
1990
Internal Medicine

Hospital de Clinicas of Universidade Estadual do Rio de Janeiro
Rio de Janeiro, Brazil
Brazil
1987
Internal Medicine

Residency:

University of Miami Jackson Memorial Medical Center
Miami, FL
1992
Internal Medicine

Hospital dos Servidores do Rio de Janeiro
Rio de Janeiro, Brazil
Brazil
1989
Nephrology

Fellowships:

Oregon Health & Science University
Portland, OR
1994
Nephrology and Transplantation Medicine

Board Certifications:

American Board of Internal Medicine, Nephrology, 1997
American Board of Internal Medicine, 1993

Professional Memberships:

American College of Physicians
American Society of Nephrology
International Society of Nephrology
Jefferson County Medical Society
National Kidney Foundation

Select Recent Publications:

Hage FG, Smalheiser S, Zoghbi GJ, Perry GJ, Deierhoi M, Warnock D, Iskandrian AE, de Mattos AM, Aqel RA. Predictors of Survival in Patients with End Stage Renal Disease Evaluated for Kidney Transplantation. American Journal of Cardiology, 100(6): 1020-1025, 2007

Chandrakantan A, de Mattos A, Naftel D, Crosswy A, Kirklin J, Curtis J. Increasing referral for end-stage renal disease in prior extrarenal solid organ transplant recipients at a single center. Clinical Journal of American Society of Nephrology 1 (4): 832-836, 2006.

de Mattos A, Prather J, Olyaei A, Shibagaki Y, Keith D, Mori M, Norman D, Becker T. Cardiovascular Events Following Renal Transplantation: Role of Traditional and Transplant Specific Risk Factors. Kidney International 70 (4), 757-764, 2006.

de Mattos AM, Olyaei AJ, Prather JC, Golconda MS, Barry JM, and Norman DJ. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation. Kidney International, 67: 714 - 720, 2005.

Olyaei AJ, de Mattos AM, Bennett WM. Cardiovascular complications of immunosuppressive agents in renal transplant recipients. Expert Opinion on Drug Safety, 4(1):29-44, 2005.

Hippen BE, de Mattos AM, Cook WJ, Kew CE, Gaston RS. CD20-positive infiltrates predict steroid-resistance and reduced renal allograft survival in acute cellular rejection. American Journal of Transplantation 5: 2248-2252, 2005.

Keith DS, de Mattos AM, Golconda M, Prather J, Cantarovich M, Paraskevas S, Tchervenkov J, Norman DJ. Factors Associated with Improvement in Deceased Donor Renal Allograft Function in the 1990s. Journal of the American Society of Nephrology, 16: 1512-1521, 2005

Olyaei, AJ, de Mattos AM, Bennett, WM. Cardiovascular Disease in Kidney Transplant Recipients: Are Patients Truly Stable? Graft, 7 (3): 136-155, 2005.

Taylor GS, Prather JC, Norman DJ, deMattos AM, Moglishetty G, Conlin MJ, Barry JM. Living unrelated donor renal transplantation: a single center experience. The Journal of Urology, 174: 223-225, 2005.